SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-20-208226
Filing Date
2020-08-03
Accepted
2020-08-03 17:13:04
Documents
2
Group Members
BAYER WORLD INVESTMENTS B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G d19404dsc13g.htm SC 13G 55801
2 EX-99.A d19404dex99a.htm EX-99.A 5262
  Complete submission text file 0001193125-20-208226.txt   62630
Mailing Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368
Business Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 492143081933
BAYER AKTIENGESELLSCHAFT (Filed by) CIK: 0001144145 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Subject) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90921 | Film No.: 201070035
SIC: 2834 Pharmaceutical Preparations